According to a recent study, it appears that taking a multivitamin daily could reduce the risk of cancer. A large clinical trial of nearly 15K older male physicians followed for more than a decade found that those taking a daily multivitamin experienced 8% fewer cancers than the subjects taking dummy pills. Researchers say that it's a statistically significant reduction, and the findings will be presented today at an American Association for Cancer Research conference. Vitamin Shoppe (VSI +1%) and GNC Holdings (GNC +0.3%) both move higher on the report.
According to a recent study, it appears that taking a multivitamin daily could reduce the risk...
From other sites
at CNBC.com (Nov 7, 2014)
at CNBC.com (Nov 4, 2014)
at CNBC.com (Oct 28, 2014)
at CNBC.com (Oct 27, 2014)
at CNBC.com (Sep 11, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs